France Uterine Cancer Market Size & Outlook, 2025-2033


France Uterine Cancer Market Insights

  • Based on Reed Intelligence findings, the France Uterine Cancer Market reached USD 323.19 Million in 2024 and is estimated to attain USD 512.49 Million by 2033.
  • From 2026 to 2033, the France market is expected to grow at a steady CAGR of 5.17%.
  • Within the By Type category, Endometrial Adenocarcinoma dominated in 2024 in terms of market size contribution.
  • Over the forecast period, Endometrial Adenocarcinoma is forecasted to deliver the fastest growth, positioning it as the most lucrative By Type segment.

Other Key Findings


  • France contributed 5.16% to the global Uterine Cancer Market size in 2024.
  • By 2033, United States is forecasted to remain the largest global market for Uterine Cancer Market.
  • In Europe, Germany is projected to capture the leading share of market size by 2033.
  • Among Europe markets, Germany is expected to post the fastest growth, reaching USD 861.8 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 323.19 Million
Market Size In 2033 USD 512.49 Million
Largest segment Endometrial Adenocarcinoma
Units Revenue in USD Million
CAGR 5.17% (2025-2033)
Segmnetation Covered
By Type
  1. Endometrial Adenocarcinoma
  2. Adenosquamous Carcinoma
  3. Papillary Serous Carcinoma
  4. Uterine Sarcoma
By Treatment
  1. Diagnosis
  2. Therapeutic Treatment
  3. Surgery
By End-Users
  1. Hospitals
  2. Diagnostic Centers
  3. Drug Stores
  4. Online Pharmacies
  5. Other End Users
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends